Navigation Links
Vanda Pharmaceuticals Reports Second Quarter 2011 Results
Date:8/4/2011

rketing and distribution support Fanapt® receives; Vanda's ability to successfully commercialize Fanapt® outside of the U.S. and Canada; delays in the completion of Vanda's clinical trials; a failure of Vanda's products, product candidates or partnered products to be demonstrably safe and effective; Vanda's failure to obtain regulatory approval for its products, product candidates or partnered products or to comply with ongoing regulatory requirements; a lack of acceptance of Vanda's products, product candidates or partnered products in the marketplace, or a failure to become or remain profitable; Vanda's expectations regarding trends with respect to its costs and expenses; Vanda's inability to obtain the capital necessary to fund additional research and development activities; Vanda's failure to identify or obtain rights to new products or product candidates; Vanda's failure to develop or obtain sales, marketing and distribution resources and expertise or to otherwise manage its growth; limitations on Vanda's ability to utilize some or all of its prior net operating losses and research and development credits; a loss of any of Vanda's key scientists or management personnel; losses incurred from product liability claims made against Vanda; a loss of rights to develop and commercialize Vanda's products or product candidates under its license and sublicense agreements and other factors that are described in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of Vanda's annual report on Form 10-K for the fiscal year ended December 31, 2010 which is on file with the SEC and available on the SEC's website at www.sec.gov.  In addition to the risks described above and in Vanda's annual report on Form 10-K and quarterly reports on Form 10-Q, other unknown or unpredictable factors also could affect Vanda's results. There can be no assurance that the actual res
'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
4. Vanda Presents Phase III Iloperidone Efficacy Data
5. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
6. Vanda Pharmaceuticals Provides Update on Iloperidone
7. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
8. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
10. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
11. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... -- Codman Neuro*, part of DePuy Synthes Companies of ... embolic coils for the treatment of brain aneurysms, supported ... stability and provide an optimized detachment zone for coils ... Society of NeuroInterventional Surgery (SNIS) 12 th Annual ... finishing coils used during a minimally invasive endovascular procedure ...
(Date:7/28/2015)... , July 28, 2015  Insulet Corporation (NASDAQ: ... technology with its OmniPod ® Insulin Management System, ... been appointed to Insulet,s Board of Directors. ... healthcare experience to the Insulet Board. She currently serves ... Joslin Diabetes Center, the world,s largest diabetes research center, ...
(Date:7/28/2015)... Colo. , July 28, 2015   ... the "Company"), a provider of  advanced veterinary diagnostic ... the availability of the new Element i ® ... testing and screening for key health concerns, including ... Element i is a compact bench top analyzer ...
Breaking Medicine Technology:Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 2Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 3Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 4Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3Heska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes 2Heska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes 3
... Leading health sciences publisher makes key ... UN developing world research access program ... information products and services, today announced that it is ... , a public-private partnership working to achieve the UN,s ...
... (NASDAQ: LMNX ) today announced that it expects ... on Tuesday, November 1, 2011.  A press release announcing ... of trading. (Logo:   http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... the operating highlights and financial results for the third quarter ...
Cached Medicine Technology:Elsevier Offers 950 New Health Titles to Research4Life 2Elsevier Offers 950 New Health Titles to Research4Life 3Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011 2Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011 3
(Date:7/29/2015)... IL (PRWEB) , ... July 29, 2015 , ... People ... benefit from two new products on Mercola.com: a vertical “garden tower” and enhanced mineral ... can be squeezed into small corners on a porch, balcony, or rooftop – can ...
(Date:7/29/2015)... ... July 29, 2015 , ... One of the world’s leading ... the potentially lifesaving impact of removing aluminum from Alzheimer’s disease patients, announced the ... is based on a successful pilot study published in The Journal of Alzheimer’s ...
(Date:7/29/2015)... ... July 29, 2015 , ... EndoMune Advanced ... chewable version of its EndoMune Jr. probiotic supplement for children ages 3-8. , ... children can enjoy to maintain a healthy balance of beneficial gut bacteria,” said ...
(Date:7/29/2015)... ... ... One may not expect to encounter a kickball game or the sound ... happening on the campus of Piedmont Crossing , a local 60-acre retirement community. ... , a five-star childcare center which operates on the same campus. As many as ...
(Date:7/29/2015)... ... July 29, 2015 , ... Nature’s Artisan, a new holistic ... gourmet flavors. , Nature’s Artisan was founded by Tina Yarandi, who came up with ... UCLA School of Dentistry. Tina was amazed when she learned about the incredible dental ...
Breaking Medicine News(10 mins):Health News:Mercola.com Introduces NEW Garden Tower and Enhanced Mineral Solution for Healthy Plants 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 2Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 2Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 4Health News:Discover a New Take on Oral Care with Nature’s Artisan Gourmet Mouthwashes 2
... and interactions between noncoding genes play a much greater ... research, published by Cell Press in the September issue ... identifying tumor-specific signatures associated with diagnosis, prognosis, and treatment ... oncogenes or tumor suppressor genes. More recently, a large ...
... implanted in the skull that detects oncoming seizures, then delivers ... is under study at the Medical College of Georgia. , ... to determine if the neurostimulator device can help patients whose ... constantly monitors electrical activity of the brain, gets accustomed to ...
... LINDA, Calif., Sept. 10 Loma Linda ... Adventist institution located,in Southern California, has chosen ... referrals and outbound reminder calls for its ... physician referrals for breast care, psychology, urology,gynecology, ...
... entries reveal wellness trends of on-staff pharmacists, ... a focus on healthy aging, CHICAGO, Sept. ... the third-annual Health at Work Award: Sprint; Erie ... Library District. Winners,were selected based on their wellness ...
... Merger and Manage Company Company Announces ... 10 Arrow International,Inc. (Nasdaq: ARRO ), a ... critical and cardiac care, reported that Glass,Lewis & Co., ... to,approve Arrow,s planned $45.50 merger with Teleflex Incorporated (NYSE:,TFX) ...
... Robbins & Myers, Inc.,(NYSE: RBN ) announced ... year results for 2007, which ended August 31, 2007, ... live webcast of the conference call,will be held at ... Robbins & Myers will be Peter C. Wallace, President ...
Cached Medicine News:Health News:Altered expression of ultraconserved noncoding RNAs linked to human leukemias and carcinomas 2Health News:Implantable device designed to detect, stop seizures under study at MCG 2Health News:Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Women's Services Programs and Departments 2Health News:ComPsych(R) Corp. Announces Health at Work(SM) Award Winners: Sprint, Erie Insurance, City of Naperville and Green Hills Public Library 2Health News:Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting 2Health News:Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting 3
... 420 CPAP System is the smallest and ... on the market. It is designed to ... lifestyles while complying with therapy. The GoodKnight ... of date/time usage data. It also detects ...
Micro-hematocrit tubes available in multiple sizes and additives for a wide range of capillary blood collection....
... VH IVUS technology uses advanced spectral ... of ultrasound images and provide detailed ... patient's atherosclerotic plaques. The colorized VH ... fibrous, fibro-fatty, dense calcium, and necrotic ...
... the GE Innova 2100IQ: See the finest ... Place interventional devices. Its all enabled by ... that helps deliver excellent image quality and ... family systems installed worldwide, more physicians rely ...
Medicine Products: